AB142080
Tetrahydrouridine, cytidine deaminase inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
Tetrahydrouridine (ab142080) is a potent competitive cytidine deaminase (CDA) inhibitor (IC50= 152 µM) that modulates antiproliferative effects. The molecular weight of Tetrahydrouridine (THU) is 248.23 g/mol.
- Orally active
- Available in different sizes to fit your experiment needs
- Orally active
- Available in different sizes to fit your experiment needs
1 Images
- Chemical Structure
Lab
Chemical Structure - Tetrahydrouridine, cytidine deaminase inhibitor (AB142080)
2D chemical structure image of ab142080, Tetrahydrouridine, cytidine deaminase inhibitor
Product details
Tetrahydrouridine (THU) is a synthetic pyrimidine nucleoside analogue and is a well characterized and potent inhibitor of cytidine deaminase (CDA). Cytidine deaminase is a key enzyme involved in the pyrimidine salvage pathway.
Use our Tetrahydrouridine, cytidine deaminase inhibitor (ab142080) for applications related to nucleotide metabolism and cancer-programmed cell death.
This product is manufactured by BioVision, an Abcam company and was previously called 1671 Tetrahydrouridine. 1671-25 is the same size as the 25 mg size of ab142080.
Use our Tetrahydrouridine, cytidine deaminase inhibitor (ab142080) for applications related to nucleotide metabolism and cancer-programmed cell death.
This product is manufactured by BioVision, an Abcam company and was previously called 1671 Tetrahydrouridine. 1671-25 is the same size as the 25 mg size of ab142080.
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:4451 PubMed40360497
2025
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.
Applications
Unspecified application
Species
Unspecified reactive species
Julie A I Thoms,Feng Yan,Henry R Hampton,Sarah Davidson,Swapna Joshi,Jesslyn Saw,Chowdhury H Sarowar,Xin Ying Lim,Andrea C Nunez,Purvi M Kakadia,Golam Sarower Bhuyan,Xiaoheng Zou,Mary Nguyen,Elaheh S Ghodousi,Forrest C Koch,Fatemeh Vafaee,I Richard Thompson,Mohammad M Karimi,Russell Pickford,Mark J Raftery,Sally Hough,Griselda Buckland,Michelle Bailey,Yuvaraj Ghodke,Noorul Absar,Lachlin Vaughan,Leonardo Pasalic,Chun Y Fong,Melita Kenealy,Devendra K Hiwase,Rohanna I Stoddart,Soma Mohammed,Linda Lee,Freda H Passam,Stephen R Larsen,Kevin J Spring,Kristen K Skarratt,Patricia Rebeiro,Peter Presgrave,William S Stevenson,Silvia Ling,Campbell Tiley,Stephen J Fuller,Fernando Roncolato,Anoop K Enjeti,Dirk Hoenemann,Charlotte Lemech,Christopher J Jolly,Stefan K Bohlander,David J Curtis,Jason W H Wong,Ashwin Unnikrishnan,Mark Hertzberg,Jake Olivier,Mark N Polizzotto,John E Pimanda
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com